Centre Hospitalier de Belfort-Montbéliard, Department of Neurology, 2, rue du Docteur Flamand, 25209 Montbéliard, France.
NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrueck Center for Molecular Medicine, Berlin, Germany; Experimental and Clinical Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine Berlin, Germany.
Sleep Med. 2014 Jan;15(1):5-14. doi: 10.1016/j.sleep.2013.08.791. Epub 2013 Nov 15.
Treatment of multiple sclerosis (MS)-related fatigue is still a challenging task, given that no proven therapies exist and its mechanisms are not known. Our review highlights the relationship between MS-related fatigue and sleep disorders (SD). Although many studies suggest a higher overall prevalence of SD in MS, there are no valid and robust data to confirm this hypothesis until now except for restless legs syndrome (RLS): the prevalence of RLS in MS patients-especially in those with severe pyramidal and sensory disability-seems to be four times higher than in controls subjects. RLS is sometimes difficult to distinguish from spasticity and in case of doubt, probatory dopaminergic therapy or polysomnographic (PSG) investigations may be helpful. Nocturia may impact MS-related fatigue and should be considered. The treatment of underlying SD led to an improvement of MS-related fatigue. From a scientific point of view, SD should be examined in all studies investigating MS-related fatigue and be considered as a relevant confounder.
治疗多发性硬化症(MS)相关疲劳仍然是一项具有挑战性的任务,因为目前尚无经过验证的治疗方法,其发病机制也尚不清楚。我们的综述强调了 MS 相关疲劳与睡眠障碍(SD)之间的关系。尽管许多研究表明 MS 患者的 SD 总体患病率较高,但到目前为止,除不安腿综合征(RLS)外,尚无有效且可靠的数据来证实这一假设:MS 患者,尤其是严重的锥体束和感觉功能障碍患者,RLS 的患病率似乎比对照组高四倍。RLS 有时难以与痉挛相区别,如有疑问,可进行试探性多巴胺能治疗或多导睡眠图(PSG)检查。夜尿症可能会影响 MS 相关疲劳,应予以考虑。治疗潜在的 SD 可改善 MS 相关疲劳。从科学的角度来看,在所有研究 MS 相关疲劳的研究中都应检查 SD,并将其视为相关的混杂因素。